Malaysia
Search
Sign In
Neurology
Top Medical News
Acupuncture appears to be beneficial in the treatment of anxiety in patients with Parkinson’s disease, according to a study.
Remotely supervised transcranial direct current stimulation (tDCS) helps improve cognitive function in stroke survivors, especially those with moderate cognitive decline, according to a study from Korea.
Distress levels are high among patients with high-grade gliomas (HGG) and demonstrate high unmet need for distress screening and referral services, a new study has found.
Atrial fibrillation (AF) exacerbates the effect of air pollution exposure on acute ischaemic stroke outcomes, such that AF patients are more likely to develop stroke when exposed to increasing levels of smog (O3) and carbon monoxide (CO) compared with those who have no AF, according to a Singapore study.
Patients with Alzheimer’s disease (AD) show slightly dysregulated levels of plasma microRNAs (miRNA), including miRNA-92a-3p and miRNA-29a-3p, a recent study has found.
A soft, miniaturized bioresorbable implant that delivers focused, minimally invasive cooling power in living tissues can help alleviate pain on demand without the use of medications and may provide an alternative to opioids and other highly addictive painkillers.
Improvements in cardiovascular health (CVH) appear to exert a strong protective effect against dementia in older Asians, reports a recent Korea study.
Special Reports
Galcanezumab Injection
Multiple sclerosis (MS) is one of the most common neurological disorders – affecting over 2.3 million people globally – and it is the leading cause of nontraumatic disability in young adults. However,the availability of supportive resources and services for people with MS is scarce in many regions of the world. In Malaysia, the prevalence of MS is estimated at 2-3/100,000; the current Malaysian clinical practice guidelines on the management of MS recommend disease modifying agents, such as interferon-β and teriflunomide, as first-line therapeutic agents. In this article, Dr Singer - in partnership with Sanofi and the Malaysian Society of Neurosciences - shares his insights into managing MS dynamically, highlighting the importance of early intervention in improving patient outcomes.
Conference Reports
High consumption of ultra-processed food (UPF) appears to be associated with a rapid decline in cognitive function in adults, according to the ELSA-Brasil* study presented at AAIC 2022.
Individuals with a history of hypertensive disorders of pregnancy (HDP) appear to have an increased risk of developing dementia, particularly vascular dementia, according to a study presented at AAIC 2022.
Older adults who have been admitted to the intensive care unit (ICU) may have an elevated risk of developing Alzheimer’s dementia or all types of dementia, according to a study presented at AAIC 2022.
Treatment with brexpiprazole at either 2 or 3 mg significantly reduced agitation compared with placebo in patients with Alzheimer’s dementia, according to the Trial 331-14-213* presented at AAIC 2022.
Studies presented at AAIC 2022 show that dancing could be a protective factor against the development of Alzheimer’s disease (AD) and dementia in older adults.
Post hoc data from a phase II study presented at AAIC 2022 continue to demonstrate the potential of masupirdine (SUVN-502), a selective 5-HT6 receptor antagonist, as a treatment alternative for the management of neuropsychiatric and cognitive symptoms of Alzheimer’s disease (AD).
Intensive care unit (ICU) hospitalization doubles the risk of subsequent dementia in older adults, a longitudinal study suggests.